AAAQX | CAIBX | AAAQX / CAIBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 38 years | - |
Gain YTD | 3.407 | 5.090 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.18B | 110B | 4% |
Annual Yield % from dividends | 1.79 | 3.28 | 55% |
Returns for 1 year | 10.69 | 12.15 | 88% |
Returns for 3 years | 3.15 | 13.84 | 23% |
Returns for 5 years | 23.74 | 27.82 | 85% |
Returns for 10 years | 52.48 | 35.74 | 147% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HDOGX | 14.01 | 0.06 | +0.43% |
Hennessy Total Return Investor | |||
FBTDX | 111.16 | -0.66 | -0.59% |
Franklin Biotechnology Discovery C | |||
DISMX | 15.50 | -0.15 | -0.96% |
DFA International Small Cap Growth | |||
MBCNX | 15.79 | -0.39 | -2.41% |
MassMutual Blue Chip Growth R3 | |||
MLACX | 4.38 | -0.11 | -2.45% |
NYLI Winslow Large Cap Growth Class C |